{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:04:18Z","timestamp":1774983858748,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["7017-00026"],"award-info":[{"award-number":["7017-00026"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005192","name":"Danmarks Tekniske Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejmech.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T19:07:25Z","timestamp":1532113645000},"page":"738-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"156","author":[{"given":"Nikolaj S.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Peir\u00f3 Cadah\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Bondebjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9649-1729","authenticated-orcid":false,"given":"Mads H.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.07.045_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.07.045_bib2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.07.045_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.07.045_bib4","first-page":"16","article-title":"Methotrexate in rheumatoid arthritis: a quarter century of development","volume":"124","author":"Weinblatt","year":"2013","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose Methotrexate\u202f: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Rev. Pharmacol"},{"key":"10.1016\/j.ejmech.2018.07.045_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00003088-200342020-00003","article-title":"Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases","volume":"42","author":"Grim","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2018.07.045_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199630030-00002","article-title":"Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis","volume":"30","author":"Bannwarth","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2018.07.045_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.045_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(13)70959-9","article-title":"Prodrugs: a challenge for the drug development","volume":"65","author":"Zawilska","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2018.07.045_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs and development","author":"Rautio","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.045_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00280-012-2062-0","article-title":"A\u00a0review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis","volume":"71","author":"Abolmaali","year":"2013","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/ars.2006.8.243","article-title":"Hydrogen peroxide: a signaling messenger","volume":"8","author":"Stone","year":"2008","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.07.045_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/541471","article-title":"Hydrogen peroxide in inflammation: messenger, guide, and assassin","author":"Wittmann","year":"2012","journal-title":"Adv. Hematol"},{"key":"10.1016\/j.ejmech.2018.07.045_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.2013_1944","article-title":"A\u00a0study of free radical chemistry: their role and pathophysiological significance","volume":"60","author":"Gutowski","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1568010054526322","article-title":"Inflammatory cells and oxygen radicals","volume":"4","author":"Nagata","year":"2005","journal-title":"Curr. Drug Targets - Inflamm. Allergy"},{"key":"10.1016\/j.ejmech.2018.07.045_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.07.045_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","article-title":"Oxidation in rheumatoid arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2018.07.045_bib19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/ard.2010.132720","article-title":"Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice","volume":"70","author":"Wruck","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2018.07.045_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ja411547j","article-title":"In\u00a0vivo targeting of hydrogen peroxide by activatable cell-penetrating peptides","volume":"136","author":"Weinstain","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib21","doi-asserted-by":"crossref","first-page":"17836","DOI":"10.1021\/ja510421q","article-title":"Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in\u00a0vivo imaging and precise cancer treatment","volume":"136","author":"Kumar","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0076-6879(02)49342-1","article-title":"Measurement of superoxide radical and hydrogen peroxide production in isolated cells and subcellular organelles","volume":"349","author":"Boveris","year":"2002","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0891-5849(00)00261-6","article-title":"Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems","volume":"29","author":"Mueller","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2018.07.045_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4155\/tde.12.61","article-title":"ROS-activated anticancer prodrugs: a new strategy for tumorspecific damage","volume":"3","author":"Peng","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejmech.2018.07.045_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/jm2014937","article-title":"Aminoferrocene-based prodrugs activated by reactive oxygen species","volume":"55","author":"Hagen","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.045_bib26","doi-asserted-by":"crossref","first-page":"19278","DOI":"10.1021\/ja2073824","article-title":"Hydrogen peroxide inducible DNA cross-linking agents targeted","volume":"133","author":"Kuang","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib27","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1021\/jm401349g","article-title":"Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes","volume":"57","author":"Chen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.045_bib28","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1002\/chem.201200075","article-title":"ROS-inducible DNA cross-linking agent as a new anticancer prodrug building block","volume":"18","author":"Cao","year":"2012","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2018.07.045_bib29","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.1021\/ja5077684","article-title":"An activatable prodrug for the treatment of metastatic tumors","volume":"136","author":"Kim","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00775-010-0727-x","article-title":"Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide","volume":"16","author":"Daniel","year":"2011","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2018.07.045_bib31","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1002\/anie.201003819","article-title":"Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach","volume":"49","author":"Major Jourden","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.07.045_bib32","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1016\/j.bmc.2014.10.029","article-title":"Design of a hydrogen peroxide-activatable agent that specifically targets cancer cells","volume":"22","author":"Vadukoot","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.045_bib33","doi-asserted-by":"crossref","first-page":"13353","DOI":"10.1021\/jacs.6b07890","article-title":"Alcohol, aldehyde, and ketone liberation and intracellular cargo release through peroxide-mediated \u03b1-boryl ether fragmentation","volume":"138","author":"Hanna","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.07.045_bib34","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1039\/C4CC09921D","article-title":"Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs","volume":"51","author":"Perez","year":"2015","journal-title":"Chem. Commun. (J. Chem. Soc. Sect. D)"},{"key":"10.1016\/j.ejmech.2018.07.045_bib35","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1021\/acs.jmedchem.7b01775","article-title":"Synthesis and evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis","volume":"61","author":"Peir\u00f3 Cadah\u00eda","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.045_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2005.03.022","article-title":"Development and application of high throughput plasma stability assay for drug discovery","volume":"297","author":"Di","year":"2005","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.ejmech.2018.07.045_bib37","series-title":"Drug-like Prop. Concepts, Struct. Des. Methods from ADME to Toxic. Optim","first-page":"169","article-title":"Plasma stability","author":"Kerns","year":"2008"},{"key":"10.1016\/j.ejmech.2018.07.045_bib38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in\u00a0vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2018.07.045_bib39","series-title":"Drug-like Prop. Concepts, Struct. Des. Methods from ADME to Toxic. Optim","first-page":"56","article-title":"Solubility","author":"Kerns","year":"2008"},{"key":"10.1016\/j.ejmech.2018.07.045_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2249.1999.00753.x","article-title":"Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression","volume":"115","author":"Neurath","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/08923973.2015.1125917","article-title":"Old and new therapeutics for Rheumatoid Arthritis: in\u00a0vivo models and drug development","author":"Sardar","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780250801","article-title":"Collagen arthritis as a relevant model for rheumatoid arthritis","author":"Trentham","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejmech.2018.07.045_bib43","first-page":"311","article-title":"Biological actions of drug solvent","volume":"113","author":"Keleva","year":"2011","journal-title":"Period. Biol."},{"key":"10.1016\/j.ejmech.2018.07.045_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.phrs.2008.04.004","article-title":"New insights of dimethyl sulphoxide effects (DMSO) on experimental in\u00a0vivo models of nociception and inflammation","volume":"57","author":"Colucci","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.07.045_bib45","unstructured":"S.M. Robillard, H. Cruell, Patent: US 2010\/0227798 A1, 2010."},{"key":"10.1016\/j.ejmech.2018.07.045_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ardp.200700025","article-title":"Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B","volume":"340","author":"Warnecke","year":"2007","journal-title":"Arch. Pharm. (Weinheim)"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:45:53Z","timestamp":1759326353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418306019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":46,"alternative-id":["S0223523418306019"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.045","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}